Gonorrhea Treatment Sector: Growth Drivers and Challenges
Growth Drivers
- Increasing Prevalence of Gonorrhea Globally
- Growing Implementation of National Screening Programs
Challenges
- Negative Perception About People Visiting STD Clinics
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
Gonorrhea Treatment Market size is projected to witness around 3.6% CAGR during the forecast period i.e., between 2025-2037.
Increasing prevalence of gonorrhea globally and growing implementation of national screening programs will impel the market growth.
North America industry is expected to dominate majority revenue share by 2037, on the back of easy availability of advanced technology and high standards of healthcare infrastructure in the region.
The major players in the market are Pfizer Inc., Allergan Inc., F. Hoffman-La Roche Ltd, GlaxoSmithKline plc., and others.
